Show Summary Details
Page of



Dr Sue Wilson

and Prof. David J. Nutt

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 01 April 2020

- Insomnia is a major health problem and is associated with low quality of life, high absenteeism from work, and physical and mental illness

- Patients report that sleep is too short, too interrupted or of poor quality, or a combination of these

- It is important to exclude other sleep disorders as a cause of insomnia: referral to a specialist sleep centre for more assessment may be necessary in cases in which the presentation is unusual or the diagnosis is in doubt

- Overall management approaches aim to acknowledge distress, treat the primary cause, educate the patient about trigger factors, and establish good sleep habits

- Current drug treatments for insomnia are hypnotic agents that affect the gamma-aminobutyric acid (GABA)-A-benzodiazepine receptor

- Several new compounds are currently in development

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.